{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:56:00Z","timestamp":1767142560311,"version":"build-2238731810"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T00:00:00Z","timestamp":1431648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T00:00:00Z","timestamp":1431648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s12185-015-1805-1","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T23:48:19Z","timestamp":1431560899000},"page":"498-505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Persistent complete remission of acute leukemic-phase CCR4-positive gamma\u2013delta peripheral T-cell lymphoma by autologous stem cell transplantation with mogamulizumab"],"prefix":"10.1007","volume":"102","author":[{"given":"Miki","family":"Furukawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ohkawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koki","family":"Udea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ohto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuei","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuchika","family":"Takeishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,15]]},"reference":[{"key":"1805_CR1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"The non-Hodgkin\u2019s lymphoma classification project","year":"1997","unstructured":"The non-Hodgkin\u2019s lymphoma classification project. A clinical evaluation of the international lymphoma study group classification of non-hodgkin\u2019s lymphoma. Blood. 1997;89:3909\u201318.","journal-title":"Blood"},{"key":"1805_CR2","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124\u201330.","journal-title":"J Clin Oncol"},{"key":"1805_CR3","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","volume":"117","author":"DD Weisenburger","year":"2011","unstructured":"Weisenburger DD, Savage KJ, Harris NL, Gascoyne RD, Jaffe ES, MacLennan KA, et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood. 2011;117:3402\u20138.","journal-title":"Blood"},{"key":"1805_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH651>3.0.CO;2-0","volume":"191","author":"G Niedobitek","year":"2000","unstructured":"Niedobitek G, Baumann I, Brabletz T, Lisner R, Winkelmann C, Helm G, et al. Hodgkin\u2019s disease and peripheral T-cell lymphoma: composite lymphoma with evidence of epstein-barr virus infection. J Pathol. 2000;191:394\u20139.","journal-title":"J Pathol"},{"key":"1805_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5858\/2006-130-107-CLHLAP","volume":"130","author":"S Sanchez","year":"2006","unstructured":"Sanchez S, Holmes H, Katabi N, Newman J, Domiatti-Saad R, Stone M, et al. Composite lymphocyte-rich Hodgkin lymphoma and peripheral T-cell lymphoma associated with Epstein-Barr virus: a case report and review of the literature. Arch Pathol Lab Med. 2006;130:107\u201312.","journal-title":"Arch Pathol Lab Med"},{"key":"1805_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1365-2559.2006.02490.x","volume":"49","author":"L Pajor","year":"2006","unstructured":"Pajor L, Kajt\u00e1r B, J\u00e1ks\u00f3 P, Lacza \u00c1, L\u00e1szl\u00f3 R, Radv\u00e1nyi G, et al. Epstein-Barr virus-induced B-cell proliferation of Hodgkin\u2019s and Reed-Sternberg cell pheno- and genotype may develop in peripheral T-cell lymphomas. Histopathology. 2006;49:553\u20137.","journal-title":"Histopathology"},{"key":"1805_CR7","doi-asserted-by":"publisher","first-page":"6756","DOI":"10.1182\/blood-2010-05-231548","volume":"117","author":"FM Foss","year":"2011","unstructured":"Foss FM, Zinzani PL, Vose JM, Gascoyne RD, Rosen ST, Tobinai K. Peripheral T-cell lymphoma. Blood. 2011;117:6756\u201367.","journal-title":"Blood"},{"key":"1805_CR8","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-04-0371","volume":"10","author":"T Ishida","year":"2004","unstructured":"Ishida T, Inagaki H, Utsunomiya A, Takatsuka Y, Komatsu H, Iida S, et al. CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified. Clin Cancer Res. 2004;10:5494\u2013500.","journal-title":"Clin Cancer Res"},{"key":"1805_CR9","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.4049\/jimmunol.0900699","volume":"183","author":"A Ito","year":"2009","unstructured":"Ito A, Ishida T, Utsunomiya A, Sato F, Mori F, Yano H, et al. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD\/Shi-scid, IL-2R gamma (null) mice in vivo. J Immunol. 2009;183:4782\u201391.","journal-title":"J Immunol"},{"key":"1805_CR10","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","volume":"28","author":"K Yamamoto","year":"2010","unstructured":"Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K, et al. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol. 2010;28:1591\u20138.","journal-title":"J Clin Oncol"},{"key":"1805_CR11","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1200\/JCO.2013.52.0924","volume":"32","author":"M Ogura","year":"2014","unstructured":"Ogura M, Ishida T, Hatake K, Taniwaki M, Ando K, Tobinai K, et al. Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-CC chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma. J Clin Oncol. 2014;32:1157\u201363.","journal-title":"J Clin Oncol"},{"key":"1805_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/ajh.23919","volume":"90","author":"L Arcaini","year":"2015","unstructured":"Arcaini L, Morello L, Tucci A, Rusconi C, Ladetto M, Rattotti S, et al. Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed\/refractory follicular lymphoma. Am J Hematol. 2015;90:230\u20134.","journal-title":"Am J Hematol"},{"key":"1805_CR13","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/trf.12437","volume":"54","author":"K Ikeda","year":"2014","unstructured":"Ikeda K, Ohto H, Kanno T, Gonda K, Suzuki Y, Ono T, et al. Peripheral blood progenitor cell collection by two programs for autologous and allogeneic transplantation. Transfusion. 2014;54:1235\u201342.","journal-title":"Transfusion"},{"key":"1805_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/bmt.2009.165","volume":"45","author":"A Numata","year":"2010","unstructured":"Numata A, Miyamoto T, Ohno Y, Kamimura T, Kamezaki K, Tanimoto T, et al. Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group. Bone Marrow Transplant. 2010;45:311\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"1805_CR15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.25429","volume":"127","author":"H Nishikawa","year":"2010","unstructured":"Nishikawa H, Sakaguchi S. Regulatory T cells in tumor immunity. Int J Cancer. 2010;127:759\u201367.","journal-title":"Int J Cancer"},{"key":"1805_CR16","doi-asserted-by":"publisher","first-page":"17945","DOI":"10.1073\/pnas.1316796110","volume":"110","author":"D Sugiyama","year":"2013","unstructured":"Sugiyama D, Nishikawa H, Maeda Y, Nishioka M, Tanemura A, Katayama I, et al. Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans. Proc Natl Acad Sci USA. 2013;110:17945\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1805_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s12185-011-0976-7","volume":"95","author":"AM Ngoma","year":"2012","unstructured":"Ngoma AM, Ikeda K, Hashimoto Y, Mochizuki K, Takahashi H, Sano H, et al. Impaired regulatory T cell reconstitution in patients with acute graft-versus-host disease and cytomegalovirus infection after allogeneic bone marrow transplantation. Int J Hematol. 2012;95:86\u201394.","journal-title":"Int J Hematol"},{"key":"1805_CR18","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/annonc\/mdf293","volume":"13","author":"T Saito","year":"2002","unstructured":"Saito T, Matsuno Y, Tanosaki R, Watanabe T, Kobayashi Y, Tobinai K. gammadelta T-cell neoplasms: a clinicopathological study of 11 cases. Ann Oncol. 2002;13:1792\u20138.","journal-title":"Ann Oncol"},{"key":"1805_CR19","doi-asserted-by":"crossref","unstructured":"Ishida T, Jo T, Takemoto S, Suzushima H, Uozumi K, Yamamoto K, et al. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol. 2015. [Epub ahead of print].","DOI":"10.1111\/bjh.13338"},{"key":"1805_CR20","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","volume":"30","author":"F d\u2019Amore","year":"2012","unstructured":"d\u2019Amore F, Relander T, Lauritzsen GF, Jantunen E, Hagberg H, Anderson H, et al. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol. 2012;30:3093\u20139.","journal-title":"J Clin Oncol"},{"key":"1805_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12185-013-1465-y","volume":"99","author":"L Gui","year":"2014","unstructured":"Gui L, Shi Y, He X, Lei Y, Zhang H, Han X, et al. High-dose therapy and autologous stem cell transplantation in peripheral T-cell lymphoma: treatment outcome and prognostic factor analysis. Int J Hematol. 2014;99:69\u201378.","journal-title":"Int J Hematol"},{"key":"1805_CR22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fonc.2013.00138","volume":"3","author":"AP Skarbnik","year":"2013","unstructured":"Skarbnik AP, Burki M, Pro B. Peripheral T-cell lymphomas: a review of current approaches and hopes for the future. Front Oncol. 2013;3:138.","journal-title":"Front Oncol"},{"key":"1805_CR23","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/bmt.2012.268","volume":"48","author":"Y Ito","year":"2013","unstructured":"Ito Y, Miyamoto T, Chong Y, Aoki T, Kato K, Akashi K, et al. Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia\/lymphoma after umbilical cord blood transplantation. Bone Marrow Transplant. 2013;48:998\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"1805_CR24","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","volume":"102","author":"K Belhadj","year":"2003","unstructured":"Belhadj K, Reyes F, Farcet J-P, Tilly H, Bastard C, Angonin R, et al. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood. 2003;102:4261\u20139.","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1007\/s12185-015-1817-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T00:00:00Z","timestamp":1433980800000}}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-015-1805-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-015-1805-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-015-1805-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-015-1805-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T19:42:33Z","timestamp":1717875753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-015-1805-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,15]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1805"],"URL":"https:\/\/doi.org\/10.1007\/s12185-015-1805-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,15]]},"assertion":[{"value":"12 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}